Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics

被引:237
作者
Duce, James A. [1 ,2 ]
Bush, Ashley I. [1 ,3 ]
机构
[1] Mental Hlth Res Inst, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia
[3] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
Alzheimer's disease; Ageing; Copper; Zinc; Iron; Metal-protein attenuating compounds; AMYLOID PRECURSOR PROTEIN; IRON-RESPONSIVE ELEMENT; A-BETA PEPTIDE; DITHIOCARBAMATE ACTIVATES AKT; ALPHA-SECRETASE CLEAVAGE; INDUCED OXIDATIVE STRESS; TRANSGENIC MOUSE MODEL; CYTOCHROME-C-OXIDASE; KAPPA-B ACTIVATION; P70; S6; KINASE;
D O I
10.1016/j.pneurobio.2010.04.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The equilibrium of metal ions is critical for many physiological functions, particularly in the central nervous system, where metals are essential for development and maintenance of enzymatic activities, mitochondrial function, myelination, neurotransmission as well as learning and memory. Due to their importance, cells have evolved complex machinery for controlling metal-ion homeostasis. However, disruption of these mechanisms, or absorption of detrimental metals with no known biological function, alter the ionic balance and can result in a disease state, including several neurodegenerative disorders such as Alzheimer's disease. Understanding the complex structural and functional interactions of metal ions with the various intracellular and extracellular components of the central nervous system, under normal conditions and during neurodegeneration, is essential for the development of effective therapies. Accordingly, assisting the balance of metal ions back to homeostatic levels has been proposed as a disease-modifying therapeutic strategy for Alzheimer's disease as well as other neurodegenerative diseases. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 18
页数:18
相关论文
共 335 条
[41]  
BUSH AI, 1994, J BIOL CHEM, V269, P26618
[42]  
BUSH AI, 1993, J BIOL CHEM, V268, P16109
[43]   Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor [J].
Buxbaum, JD ;
Liu, KN ;
Luo, YX ;
Slack, JL ;
Stocking, KL ;
Peschon, JJ ;
Johnson, RS ;
Castner, BJ ;
Cerretti, DP ;
Black, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :27765-27767
[44]   Age- and region-dependent alterations in Aβ-degrading enzymes:: implications for Aβ-induced disorders [J].
Caccamo, A ;
Oddo, S ;
Sugarman, MC ;
Akbari, Y ;
LaFerla, FA .
NEUROBIOLOGY OF AGING, 2005, 26 (05) :645-654
[45]   BACE1 is the major β-secretase for generation of Aβ peptides by neurons [J].
Cai, HB ;
Wang, YS ;
McCarthy, D ;
Wen, HJ ;
Borchelt, DR ;
Price, DL ;
Wong, PC .
NATURE NEUROSCIENCE, 2001, 4 (03) :233-234
[46]   Intellectual impairment in children with blood lead concentrations below 10 μg per deciliter [J].
Canfield, RL ;
Henderson, CR ;
Cory-Slechta, DA ;
Cox, C ;
Jusko, TA ;
Lanphear, BP .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (16) :1517-1526
[47]   Cytochrome c oxidase is decreased in Alzheimer's disease platelets [J].
Cardoso, SM ;
Proença, MT ;
Santos, S ;
Santana, I ;
Oliveira, CR .
NEUROBIOLOGY OF AGING, 2004, 25 (01) :105-110
[48]   Neurodegeneration in amyotrophic lateral sclerosis:: the role of oxidative stress and altered homeostasis of metals [J].
Carrì, MT ;
Ferri, A ;
Cozzolino, M ;
Calabrese, L ;
Rotilio, G .
BRAIN RESEARCH BULLETIN, 2003, 61 (04) :365-374
[49]   β-amyloid catabolism:: roles for neprilysin (NEP) and other metallopeptidases? [J].
Carson, JA ;
Turner, AJ .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (01) :1-8
[50]   Iron: The redox-active center of oxidative stress in Alzheimer disease [J].
Castellani, Rudy J. ;
Moreira, Paula I. ;
Liu, Gang ;
Dobson, Jon ;
Perry, George ;
Smith, Mark A. ;
Zhu, Xiongwei .
NEUROCHEMICAL RESEARCH, 2007, 32 (10) :1640-1645